Recursion Pharmaceuticals Inc (RXRX)
5.795
+0.04
(+0.78%)
USD |
NASDAQ |
Nov 22, 14:18
Recursion Pharmaceuticals Market Cap: 1.661B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.648B |
| November 20, 2024 | 1.731B |
| November 19, 2024 | 1.797B |
| November 18, 2024 | 1.749B |
| November 15, 2024 | 1.770B |
| November 14, 2024 | 1.981B |
| November 13, 2024 | 2.098B |
| November 12, 2024 | 2.173B |
| November 11, 2024 | 2.247B |
| November 08, 2024 | 2.035B |
| November 07, 2024 | 1.986B |
| November 06, 2024 | 1.998B |
| November 05, 2024 | 1.955B |
| November 04, 2024 | 1.903B |
| November 01, 2024 | 1.835B |
| October 31, 2024 | 1.812B |
| October 30, 2024 | 1.911B |
| October 29, 2024 | 1.929B |
| October 28, 2024 | 1.966B |
| October 25, 2024 | 1.854B |
| October 24, 2024 | 1.820B |
| October 23, 2024 | 1.811B |
| October 22, 2024 | 1.891B |
| October 21, 2024 | 1.934B |
| October 18, 2024 | 1.986B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.874B |
| October 16, 2024 | 2.006B |
| October 15, 2024 | 1.909B |
| October 14, 2024 | 1.923B |
| October 11, 2024 | 1.894B |
| October 10, 2024 | 1.768B |
| October 09, 2024 | 1.760B |
| October 08, 2024 | 1.843B |
| October 07, 2024 | 1.768B |
| October 04, 2024 | 1.747B |
| October 03, 2024 | 1.733B |
| October 02, 2024 | 1.747B |
| October 01, 2024 | 1.764B |
| September 30, 2024 | 1.884B |
| September 27, 2024 | 1.970B |
| September 26, 2024 | 2.024B |
| September 25, 2024 | 1.945B |
| September 24, 2024 | 1.931B |
| September 23, 2024 | 1.883B |
| September 20, 2024 | 1.919B |
| September 19, 2024 | 1.959B |
| September 18, 2024 | 1.950B |
| September 17, 2024 | 1.908B |
| September 16, 2024 | 1.877B |
| September 13, 2024 | 1.854B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
866.92M
Minimum
May 11 2022
6.961B
Maximum
Jul 13 2021
2.288B
Average
1.905B
Median
Nov 03 2022
Market Cap Benchmarks
| Revance Therapeutics Inc | 403.87M |
| NovaBay Pharmaceuticals Inc | 3.396M |
| Palatin Technologies Inc | 18.78M |
| iBio Inc | 23.79M |
| Theriva Biologics Inc | 3.617M |
Market Cap Related Metrics
| PS Ratio | 22.04 |
| PEG Ratio | -0.6065 |
| Price to Book Value | 3.167 |
| Price | 5.795 |
| Earnings Yield | -26.75% |
| PEGY Ratio | -0.6065 |